Texas Diabetes and Endocrinology

Name

Texas Diabetes and Endocrinology

Legal name

Texas Diabetes & Endocrinology, PA

Website

https://texasdiabetes.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Endocrinology Specialty Healthcare

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Type 2 Diabetes Care (HLAKADAC), Thyroid Disorders (HLAKADAF), Gender-Affirming Endocrine Care (HLAKADAM)

Keywords

• Endocrinology specialty care
• Diabetes management services
• Thyroid disorder treatment
• Hormone replacement therapy
• Metabolic disease care

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Medical Visits and Procedures: Revenue generated from billable office visits (new patient and established patient), diagnostic procedures (thyroid ultrasound, fine needle aspiration, FibroScan, DXA bone density scans), and in-house lab services. Payment collected at time of service for copays, coinsurance, and deductibles. Insurance billing for covered services.
2. Clinical Trial Compensation: Revenue received from pharmaceutical sponsors and CROs for conducting Phase II-IV clinical trials, observational studies, and device trials. Sponsors provide investigational product, study-related procedures, and per-visit compensation. Insurance is not billed for research visits.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Texas Diabetes & Endocrinology operates a multi-location endocrinology specialty practice delivering physician-led care for diabetes, thyroid disorders, osteoporosis, hormonal and metabolic conditions. Clinical services are supported by on-site diagnostic imaging (thyroid ultrasound with FNA, FibroScan for liver health, DXA bone density scans), continuous glucose monitoring device support, and an integrated clinical trials program that provides access to investigational therapies across diabetes, thyroid, osteoporosis, and obesity.

Product overview

Texas Diabetes & Endocrinology is a multi-location endocrinology specialty clinic offering a unified, integrated suite of hormone and metabolic care services. The core clinical portfolio spans diabetes management (type 1, type 2, gestational), thyroid imaging and disorders, osteoporosis and fracture care, heart disease prevention, liver health testing, medical weight loss, pituitary and adrenal disorders, PCOS, testosterone replacement therapy, and gender-affirming hormone therapy. These services are supported by on-site diagnostic technologies including FibroScan (liver), DXA bone density scanning, and thyroid ultrasound with fine needle aspiration, as well as CGM and insulin pump therapy for diabetes. The patient-facing digital layer includes the MyTDE Patient Portal (powered by MyMedAccess) for secure record access, appointment management, and provider messaging; Auto Pay via Phreesia for billing; and lab integrations with Quest, LabCorp, Babson Diagnostics, and Clinical Pathology Labs. The practice also runs an active clinical research department conducting paid Phase II-IV trials across its three sites.

Differentiator

Problem solved

Functional benefit

Brands

• MyTDE Patient Portal: A secure, HIPAA-compliant online patient portal providing 24/7 access to medical information, lab results, prescription refills, appointment requests, and secure messaging with the care team.

Products and services

• Diabetes Care Personalized, evidence-based care for individuals with type 1, type 2, or gestational diabetes delivered by board-certified endocrinologists and Certified Diabetes Care and Education Specialists (CDCES), including treatment plans, medication management, CGM, and insulin pump therapy.
• Thyroid Imaging and Disorder Care Comprehensive thyroid care including on-site thyroid ultrasound, fine needle aspiration (FNA) of thyroid nodules, and treatment for hypothyroidism, hyperthyroidism, Hashimoto's, and thyroid cancer surveillance, available to adult patients referred by their primary care physician.
• Osteoporosis and Fracture Care Advanced screening, diagnosis, and treatment for osteoporosis, osteopenia, and metabolic bone disorders, including on-site DXA bone density scanning, lab testing, and FDA-approved medication management.
• Heart Disease Prevention Evidence-based cardiovascular prevention program integrating metabolic testing, advanced lipid panels (including ApoB and hsCRP), cardiovascular risk scoring, and personalized counseling to prevent heart attacks and strokes in patients with diabetes, PCOS, hypertension, dyslipidemia, obesity, or family history of cardiovascular disease.
• Liver Health Testing (FibroScan) Non-invasive liver health assessment using FibroScan technology to measure liver stiffness and fat content (steatosis), along with liver function blood panels, for early detection of MASLD, MASH, and other liver conditions.
• Medical Weight Loss Physician-led weight loss program using FDA-approved medications including GLP-1 agonists (semaglutide, tirzepatide), with metabolic evaluation, ongoing monitoring, and Registered Dietician referrals for adults categorized as overweight or obese with or without weight-related comorbidities.
• Pituitary and Adrenal Disorder Care Diagnosis and management of pituitary and adrenal gland conditions including pituitary tumors, Cushing's syndrome, Addison's disease, acromegaly, and congenital adrenal hyperplasia, with hormone testing (ACTH/cortisol) and imaging referrals.
• PCOS Treatment Hormonal and metabolic evaluation, diagnosis, and personalized treatment for polycystic ovary syndrome including hormonal regulation, insulin-sensitizing medications, GLP-1 therapy for weight management, and fertility support coordination for women of reproductive age.
• Testosterone Replacement Therapy (TRT) Clinically guided testosterone replacement therapy for men with confirmed low testosterone (hypogonadism), including comprehensive hormone panels, customized therapy plans (gel, oral, or injection), and ongoing monitoring for prostate and cardiovascular health.
• Gender-Affirming Hormone Therapy (GAHT) Medically guided hormone therapy for transgender and non-binary adults following WPATH Standards of Care, including testosterone therapy, estrogen therapy, anti-androgens, and long-term hormone maintenance and monitoring in an affirming clinical environment.
• Continuous Glucose Monitoring (CGM) Service CGM sensor placement, data review, and remote monitoring service for diabetes patients, supporting Dexcom and FreeStyle Libre devices with app integration.
• Insulin Pump Therapy Service Training and support for insulin pump therapy in diabetes management, integrated with CGM devices for comprehensive diabetes technology.
• Clinical Trials Research Program Paid clinical trials for type 1 and type 2 diabetes, thyroid disorders, osteoporosis, weight management, and other endocrine conditions, conducted at three research sites integrated within clinic locations and offering participants access to investigational therapies and devices.

Quantifiable outcome

• 500+ Happy Patients (self-reported patient satisfaction metric on homepage)

Named customers1 record

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature4 records

Partnerships

One partnership is on record.

• Pharmaceutical Sponsors and CROscoreOthersTexas Diabetes & Endocrinology conducts clinical trials in partnership with pharmaceutical sponsors and contract research organizations (CROs). Sponsors provide investigational medications, devices, and study funding. The practice has 10+ years of clinical and device research experience, participating in studies involving new oral agents and injectables for diabetes treatment, CGM and pump devices, and other oral/injectable medications. No specific sponsor names are publicly disclosed on the website.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Virta Health: Telehealth diabetes reversal and type 2 diabetes management platform combining nutrition, medication management, and remote monitoring. Competes with TDE on diabetes care delivery model, especially for patients seeking app-based, continuous remote support.
• 9amHealth: Telehealth clinic focused on diabetes, prediabetes, hypertension, and weight management, prescribing GLP-1s and providing continuous care. Directly competes with TDE's diabetes, weight-loss, and cardiometabolic service lines for patients willing to accept virtual-first care.
• Form Health: Telehealth medical weight loss clinic staffed by physicians, dietitians, and behavior coaches, prescribing FDA-approved obesity medications including GLP-1s. Direct competitor to TDE's Medical Weight Loss service line, particularly for self-paying patients.
• Found: Telehealth weight care platform combining behavior therapy, nutrition guidance, and obesity medication prescriptions. Competes with TDE for patients seeking accessible, often self-pay weight-loss treatment without geographic or PCP referral constraints.

Emerging players

• Ro: Direct-to-patient telehealth platform with endocrinology, weight loss (including GLP-1s), thyroid care, and men's health verticals. Overlaps with TDE's diabetes, thyroid, weight-loss, and TRT offerings via a national digital channel.
• Maven Clinic: Virtual clinic for women's and family health, with strong PCOS, fertility, and hormonal care offerings. Overlaps with TDE's PCOS and women's hormonal health segments through a digital-first model that competes for self-directed patients.

Regional players

• UT Health Austin: Academic medical practice affiliated with Dell Medical School providing specialty endocrinology care in Austin. Competes with TDE for complex endocrinology referrals and benefits from a teaching hospital's brand and academic affiliations.
• Austin Regional Clinic: Large multi-specialty physician group in Central Texas with internal endocrinology coverage. Competes with TDE for PCP referrals and patients seeking endocrinology care within an integrated multi-specialty network in the same Austin market.

Broad incumbents

• Baylor Scott & White Health: Large not-for-profit health system with multi-specialty endocrinology practices in Texas. Competes with TDE for specialty endocrinology referrals across the broader Central Texas region and offers the scale and payer leverage of a major integrated delivery network.
• Hims & Hers Health: National telehealth platform offering weight loss (including GLP-1s), hormone therapy, and primary care across multiple specialties. Increasingly competes with TDE in weight management, thyroid, and hormone-replacement categories at a national, brand-driven scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Texasdiabetes
• LinkedInlinkedin.com/company/texas-diabetes-&-endocrinology-p.a.
• Instagraminstagram.com/txdiabetes

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Texas Diabetes and Endocrinology